Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Optic Neuritis
In brief
The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).
Key facts
- Study ID
- NCT07623668
- Run by
- Oculis
- People needed
- 210
- Starts
- 2026-05-28
- Expected to finish
- 2028-12-01
- Last updated by the study team
- 2026-07-01
Who can join
Age: 18 and older, up to 50. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kahana Oculoplastic and Orbital Surgery — Livonia, Michigan, United States (enrolling)
- Neuro-Eye Clinical Trials — Houston, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.